Peter Howarth Selected Research

Peter Howarth Research Topics

Disease

52	Asthma (Bronchial Asthma) 12/2023 - 05/2003
11	Inflammation (Inflammations) 10/2023 - 08/2012
4	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 03/2013
2	Nasal Polyps (Nasal Polyp) 10/2023 - 01/2023
2	Rhinosinusitis 10/2023 - 01/2023
2	COVID-19 04/2021 - 01/2021
2	Eosinophilia 01/2021 - 02/2017
1	Churg-Strauss Syndrome (Allergic Angiitis) 12/2023
1	Hypersensitivity (Allergy) 01/2023
1	Infections 10/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Symptom Flare Up 01/2022
1	Bronchiectasis 12/2021
1	Allergic Bronchopulmonary Aspergillosis 12/2021
1	Airway Obstruction (Choking) 01/2021
1	Rhinitis 01/2021
1	Dysbiosis 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2019
1	Airway Remodeling 01/2017
1	Lung Neoplasms (Lung Cancer) 03/2013
1	Pathologic Processes 03/2013
1	Lung Diseases (Lung Disease) 03/2013
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2010
1	Rhinorrhea 01/2002

Drug/Important Bio-Agent (IBA)

23	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 08/2012
17	mepolizumabIBA 12/2023 - 08/2012
12	Biomarkers (Surrogate Marker)IBA 10/2023 - 05/2010
6	SteroidsIBA 10/2022 - 08/2012
4	Interleukin-13IBA 11/2023 - 01/2017
4	Bronchodilator Agents (Bronchodilators)IBA 10/2023 - 01/2017
4	CytokinesIBA 10/2023 - 02/2016
4	AllergensIBA 01/2022 - 07/2003
4	Immunoglobulin E (IgE)IBA 12/2021 - 05/2003
3	Monoclonal AntibodiesIBA 01/2022 - 08/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 02/2017
3	Proteins (Proteins, Gene)FDA Link 10/2020 - 05/2010
2	InflammasomesIBA 11/2023 - 01/2021
2	Interleukin-8 (Interleukin 8)IBA 10/2022 - 11/2019
2	FurinIBA 02/2021 - 01/2021
2	Omalizumab (Xolair)FDA Link 01/2021 - 01/2021
2	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 01/2019
2	AntibodiesIBA 10/2020 - 08/2012
2	ProteomeIBA 01/2019 - 01/2018
2	InterleukinsIBA 12/2018 - 08/2012
2	Enterotoxins (Enterotoxin)IBA 08/2012 - 05/2003
1	VaccinesIBA 11/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	GlucocorticoidsIBA 03/2023
1	Chemotactic FactorsIBA 10/2022
1	benralizumabIBA 03/2022
1	dupilumabIBA 03/2022
1	P-2 (P 2)IBA 01/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	AcidsIBA 01/2022
1	fezakinumabIBA 01/2022
1	ElementsIBA 12/2021
1	EndopeptidasesIBA 01/2021
1	ProstaglandinsIBA 01/2021
1	Prostaglandin D2IBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	LeukotrienesIBA 01/2021
1	EicosanoidsIBA 01/2021
1	Leukotriene E4IBA 01/2021
1	IsoprostanesIBA 01/2021
1	Eosinophil-Derived NeurotoxinIBA 01/2020
1	DefensinsIBA 11/2019
1	Interleukin-17 (Interleukin 17)IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	Thromboxane B2IBA 11/2019
1	Volatile Organic CompoundsIBA 01/2019
1	mesoglycanIBA 01/2019
1	InterferonsIBA 01/2017
1	Chymases (Chymase)IBA 02/2015
1	CarboxypeptidasesIBA 02/2015
1	Tryptases (Tryptase)IBA 02/2015
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2015
1	SmokeIBA 01/2015
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2013
1	MicroRNAs (MicroRNA)IBA 03/2013
1	Small Untranslated RNAIBA 03/2013
1	SuperantigensIBA 08/2012
1	GoldIBA 05/2010
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2010
1	LipocalinsIBA 05/2010
1	Lipocalin 1IBA 05/2010
1	Metalloproteases (Metalloproteinases)IBA 06/2008
1	DisintegrinsIBA 06/2008
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2002

Therapy/Procedure

11	Therapeutics 01/2023 - 01/2002
3	Biological Therapy 03/2022 - 12/2018
2	Precision Medicine 01/2022 - 01/2019
1	Lasers (Laser) 01/2019